Significance of myocardial uptake of iodine 123-labeled beta-methyl iodophenyl pentadecanoic acid: comparison with kinetics of carbon 11-labeled palmitate in positron emission tomography
- PMID: 9420746
- DOI: 10.1007/BF02939975
Significance of myocardial uptake of iodine 123-labeled beta-methyl iodophenyl pentadecanoic acid: comparison with kinetics of carbon 11-labeled palmitate in positron emission tomography
Abstract
Background: A radioactively labeled beta-methyl branched fatty acid analog, 123I-15-(p-iodophenyl)-3-methyl pentadecanoic acid (BMIPP), has been developed to probe regional myocardial fatty acid metabolism. However, the significance of BMIPP uptake in the myocardium remains unclear.
Methods and results: To evaluate the significance of BMIPP uptake, single-photon emission computed tomography was performed 30 minutes after injection of BMIPP, and 201Tl-labeled single-photon emission computed tomography was taken on a separate day in 10 patients. Findings of BMIPP and 201Tl-labeled imaging were compared with the data obtained from positron emission tomography with 11C-labeled palmitate. The BMIPP uptake (percent of maximum) was significantly correlated with the early uptake (percent) and delayed uptake (percent) of 11C-labeled palmitate (r = 0.659 and r = 0.687, respectively) (p < 0.01 each), whereas it was not significantly correlated with the residual fraction (r = 0.205) or the clearance half-time of the early component (r = 0.138) of 11C-labeled palmitate as a marker of beta-oxidation of the fatty acid.
Conclusions: These data indicate that, although the myocardial uptake of BMIPP may not directly reflect beta-oxidation of fatty acids, its uptake may reflect both regional myocardial blood flow and fatty acid extraction.
Similar articles
-
Basic kinetics of 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in canine myocardium.Int J Card Imaging. 1999 Feb;15(1):11-20. doi: 10.1023/a:1006167713330. Int J Card Imaging. 1999. PMID: 10453398 Review.
-
Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP.J Nucl Med. 1997 Jul;38(7):1079-84. J Nucl Med. 1997. PMID: 9225794
-
Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid.Eur J Nucl Med. 1995 Dec;22(12):1385-92. doi: 10.1007/BF01791146. Eur J Nucl Med. 1995. PMID: 8586083
-
Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP.J Nucl Med. 1997 Oct;38(10):1503-10. J Nucl Med. 1997. PMID: 9379183
-
beta-Methyl-p-(123I)-iodophenyl pentadecanoic acid single-photon emission computed tomography in cardiomyopathy.Int J Card Imaging. 1999 Feb;15(1):41-8. doi: 10.1023/a:1006188301035. Int J Card Imaging. 1999. PMID: 10453402 Review.
Cited by
-
BMIPP compared with PET metabolism.Int J Card Imaging. 1999 Feb;15(1):61-9. doi: 10.1023/a:1006148619691. Int J Card Imaging. 1999. PMID: 10453404
-
Serial evaluation of fatty acid metabolism in rats with myocardial infarction by pinhole SPECT.J Nucl Cardiol. 2001 Jul-Aug;8(4):472-81. doi: 10.1067/mnc.2001.114519. J Nucl Cardiol. 2001. PMID: 11481570
-
Basic kinetics of 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in canine myocardium.Int J Card Imaging. 1999 Feb;15(1):11-20. doi: 10.1023/a:1006167713330. Int J Card Imaging. 1999. PMID: 10453398 Review.
-
Radiopharmaceuticals for cardiac imaging: Current status and future trends.J Nucl Cardiol. 2018 Aug;25(4):1242-1246. doi: 10.1007/s12350-018-1194-y. Epub 2018 Feb 7. J Nucl Cardiol. 2018. PMID: 29417412 No abstract available.
-
Future aspects of BMIPP.Int J Card Imaging. 1999 Feb;15(1):79-89. doi: 10.1023/a:1006109022417. Int J Card Imaging. 1999. PMID: 10453406 Review.